Table 1.
Quality score items.
Item | Score point allocation | Item | Score point allocation |
---|---|---|---|
Category 1: Reporting of study subject details and welfare | Category 2: Study planning quality | ||
1. Animal protocol approved | Reported yes = 1/no = 0 | 1. Study hypothesis | Reported yes = 1/no = 0 |
2. Species | Reported yes = 1/no = 0 | 2. A priori endpoint definition | Reported yes = 1/no = 0 |
3. Sex and age | Reported yes = 1/no = 0 | 3. A priori sample size calculation | Reported yes = 1/no = 0 |
4. Pre-study health | Reported yes = 1/no = 0 | 4. Reference to previous studies | Reported yes = 1/no = 0 |
5. Comorbidities | Reported yes = 1/no = 0 | 5. Inclusion/exclusion criteria | Reported yes = 1/no = 0 |
6. Adequate medication | Reported yes = 1/no = 0 | 6. Effect size/treatment effect | Reported yes = 1/no = 0 |
Category 3: Internal study validity | Category 4: Outcome analysis and reporting | ||
1. Blinding | Reported yes = 1/no = 0 | 1. Individual data points | Reportedyes = 1/no = 0 |
2. Randomization | Reported yes = 1/no = 0 | 2. Drop outs/excluded subjects | Reported yes = 1/no = 0 |
3. Allocation concealment | Reported yes = 1/no = 0 | 3. Appropriate statistical tests | Used yes = 1/no = 0 |
4. Physiological parameters | Measuring reported yes = 1/no = 0 | 4. Potential error sources | Reported yes = 1/no = 0 |
5. Analysis modalities | Appropriate modalities reporteda yes = 1/no = 0 | 5. Study/methodological limits | Reported yes = 1/no = 0 |
6. Infarct induction confirmation | Reported yes = 1/no = 0 | 6. Justified conclusion givenb | Provided yes = 1/no = 0 |
aAnalysis modalities were considered appropriate when being sufficient to assess the respective research question or endpoint (see Supplementary Table 3 for details).
bConclusion was considered justified when supported by correctly analyzed results.